My Alcon | United Kingdom

This page is available in English. Select below for other countries.

Select Another Country

Confidence:

The Alcon Advantage

IOL Options for Every Patient

 

Confidence: The Alcon Advantage

 

IOL Options for Every Patient

 

 

AcrySof IQ Vivity® IOL

 

The first and only presbyopia-correcting IOL with wavefront-

shaping technology.1-4

A close-up shot of a car’s left passenger side headlight illuminating the dark. A vertical line divides the headlight in two, with a starburst effect on the light on the left side of the line.

AcrySof® IQ PanOptix® IOL

 

Patients can now enjoy excellent vision at every meaningful distance.5,6

An image of an older man and his grandson sitting on a couch smiling and looking at a tablet that appears off-screen.

AcrySof® IQ Monofocal IOL

and AcrySof® IQ Toric IOL 

 

The trusted IOLs that give you confidence.7

An image of printed research papers placed on the ground in such a way that the borders of the papers create the outline of an IOL. An iPad lies on top of the papers, displaying a title page to a study on the AcrySof IQ platform. A blue medical mask lies next to the iPad. This all appears on a grey background.

Clareon® Monofocal IOL and Clareon® Toric IOL

 

Our most advanced lens design that delivers pristine visual outcomes.8-10

A close up Image image of 2 IOL lenses overlaid with a blue background

Alcon Experience Academy

 

For relevant training content from industry thought leaders

References:
1. AcrySof IQ Vivity® Extended Vision IOL Directions for Use.
2. Alcon Data on File. US Patent 9968440 B2. 15 May 2018.
3. Alcon Data on File. TDOC-0055575. 09 Apr 2019.
4. Alcon Data on File. TDOC-0055576. 09 Apr 2019.

5. Modi S, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207.
6. Clareon® PanOptix® IOL Directions for Use.
7. Market Scope. 2020 IOL Market Report – Mid-Year Update.
8. Clareon® IOL Directions for use.
9. Werner L, Thatthamla I, Ong M, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019;45(10):1490-1497.
10. Oshika T, Fujita Y, Inamura M, Miyata K. Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl methacrylate. J Cataract Refract Surg. 2020;46(5):682-687.

11. Modi S, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207.

12. Zhu et al. Rate of Complete Spectacle Independence with a Trifocal IOL (PanOptix): A Systematic Literature Review and Meta-Analysis. Presentation at 2022 ASCRS; April 2022; Washington, D.C

13. Market Scope 2022 IOL Market Report.

14. Alcon Data on File, 2022. [REF-18881].

15. Clareon® PanOptix® Trifocal IOL Directions for Use.

 

Please refer to relevant products DFU or Operator’s manuals for complete list of indications, contraindications and warnings. Please visit ifu.alcon.com for important product information.